University of California, San Francisco: Glioma trials
The registry lists 14 Glioma studies with University of California, San Francisco as lead sponsor. 3 are open to participants now and 5 have results posted.
Phase 1 4Phase 2 6No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Assessing Brain Metabolism Using MRS With Deuterated GlucoseRecruitingNCT06594315
- DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade GliomaRecruitingNCT06504381Phase 1/2
- Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)RecruitingNCT04485559Phase 1
- Everolimus With and Without Temozolomide in Adult Low Grade GliomaTerminatedNCT02023905Phase 2Results posted
- Ovarian Aging in Low Grade Glioma (LGG) Treated With TemozolomideTerminatedNCT01452854Results posted
- Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the BrainTerminatedNCT01116661Phase 2Results posted
- Temozolomide in Treating Patients With Recurrent High-Grade GliomaCompletedNCT00619112Phase 2Results posted
- Temozolomide in Treating Patients With Low-Grade GliomaCompletedNCT00313729Phase 2Results posted
- BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV GliomasActive, not recruitingNCT03749187Phase 1
- Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaCompletedNCT03739372Not applicable
- Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor PatientsTerminatedNCT02783495Not applicable
- Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade GliomaCompletedNCT02022644Phase 1
- Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent GliomaTerminatedNCT01011231Phase 2
- Study of Blood and Cheek Cell Samples From Patients With GliomaCompletedNCT01009307